Cempra Pharmaceuticals Inc., Optimer deal

Optimer received a $500,000 milestone payment from Cempra under a 2006 deal granting Cempra rights to CEM-101. The payment was triggered by Cempra receiving FDA clearance to start a Phase II trial of...